Abstract
Studies in transgenic mouse models of Alzheimer's disease suggested the potential for a vaccine development. However, some patients in the human clinical trials developed symptoms of brain inflammation, demonstrating the high risk of a deliberately induced auto-immune response.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have